A clear view of work, value and exchange.
Four projects are documented separately from the payments and barter received. Project 1 is settled. Projects 2, 3 and 4 are each budgeted at $15,000–$25,000 in development work.
Project breakdown
Four separate projects
Project budgets are kept separate from barter and cash received so the current relationship is easy to reconcile.
Project 1
Original Financial Project
The original project was completed and made whole. Historical Barter Batch 1 was absorbed into this build and is already part of the settled exchange.
Project 2
Weight Loss Peptides Precision Research
A complete rebrand and development overhaul after the original Affordable GLP-1 Weight Loss Telehealth direction changed.
Project 3
Precision Cellular Wellness
A separate premium website and growth platform with strategy, design, development, SEO, AI optimization and ongoing expansion.
Project 4
PCW Research Peptides
A separate website and brand build including bottle branding, label direction, product presentation, SEO, AI optimization and continued expansion.
Barter Batch 2
Earlier inventory repriced
Values below use the new Precision Cellular Wellness price list. Unsupported items remain marked TBD.
Batch 2 Inventory
Currently supported value| Item | Qty | Price Each | Total |
|---|---|---|---|
| GLOW 70 mg | 8 | $70 | $560 |
| BPC-157 / TB-500 20 mg | 8 | $85 | $680 |
| SS-31 50 mg | 3 | $150 | $450 |
| NAD+ 500 mg | 3 | $50 | $150 |
| MOTS-C 40 mg | 3 | $100 | $300 |
| Reduced Glutathione 1.5 g | 5 | TBD | TBD |
| Tirzepatide 10 mg | 1 | $50 | $50 |
| Tirzepatide 20 mg | 6 | $100 | $600 |
| Retatrutide 10 mg | 4 | $80 | $320 |
| Retatrutide 12 mg | 3 | $100 | $300 |
| Currently Priced Batch 2 Total | $3,410+ | ||
Barter Batch 3
New inventory received July 27, 2026
Batch 3 is recorded independently from Batch 2. GHK-CU and bacteriostatic water remain TBD because they are not priced on the supplied list.
Batch 3 Inventory
Currently supported value| Item | Qty | Price Each | Total |
|---|---|---|---|
| MOTS-C 40 mg | 10 | $100 | $1,000 |
| SS-31 50 mg | 10 | $150 | $1,500 |
| GHK-CU 100 mg | 10 | TBD | TBD |
| BPC-157 / TB-500 20 mg | 10 | $85 | $850 |
| Bacteriostatic Water 10 mL | 20 | TBD | TBD |
| Currently Priced Batch 3 Total | $3,350+ | ||
Barter Batch 4
PCW Inventory Received – Bartering Calculator
This peptide shipment was received August 1, 2026. Each line item is calculated from the bottle quantity and agreed per-bottle barter value.
Batch 4 Peptide Inventory
Received August 1, 2026| Item | Qty | Price Each | Total |
|---|---|---|---|
| Tesamorelin / Ipamorelin 10 mg / 10 mg | 10 | $90 | $900 |
| Retatrutide 16 mg | 20 | $150 | $3,000 |
| Retatrutide 10 mg | 20 | $80 | $1,600 |
| ARA-290 10 mg | 20 | $50 | $1,000 |
| Kisspeptin 5 mg | 20 | $50 | $1,000 |
| PT-141 | 20 | $50 | $1,000 |
| NAD+ 1000 mg | 20 | $80 | $1,600 |
| Total Product Value | $10,100 | ||
Financial payments
Cash received from Marcus D. Haley
Both Bank of America transfers are documented separately from barter inventory.
Cash Payment 1
Bank of America Transfer
Financial payment received from Marcus D. Haley on July 24, 2026.
Cash Payment 2
Bank of America Transfer
Bank of America notification received July 28, 2026: “Marcus D Haley sent you $1,000.00.”
Current reconciliation
What has been received so far
Project budgets remain separate from barter and cash received. The current totals below only reflect supported list pricing.
$16,860+ in currently priced barter across Batches 2, 3 and 4, plus $2,000 in documented cash payments. Three older delivered items remain TBD.